OXURION Trademark

Trademark Overview


On Monday, June 25, 2018, a trademark application was filed for OXURION with the United States Patent and Trademark Office. The USPTO has given the OXURION trademark a serial number of 79239267. The federal status of this trademark filing is REGISTERED as of Tuesday, June 11, 2019. This trademark is owned by ThromboGenics. The OXURION trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Biopharmaceutical preparations for use in the treatment of hypertension, strokes, cardiac diseases and vascular diseases; diagnostic medical reagents, chemicals preparations and biological materials all the foregoing being in the form of spatially defined arrays and solutions and reagents for medical laboratory use in diagnosting, monitoring, and predicting diseases and for measuring and predicting response to therapy of cardiac and vascular diseases; pharmaceutical preparations for use in the treatment of hypertension, strokes, cardiac diseases and vascular diseases; pharmaceutical substances and medicines for treatment or prevention of eye disorders and diseases and of ophthalmological disorders and diseases; pharmaceutical preparations and substances for the treatment or prevention of diabetes; medicines for treating or preventing diabetes; ophthalmic medicines and surgical fluids, ophthalmic pharmaceutical preparations; pharmaceutical eye drops

Medical services; veterinary services; consultancy services, namely, consultancy in the medical, veterinary and pharmaceutical treatment of patients in the fields of ophthalmology, diabetes and cardiovascular diseases; medical services, namely, cardiac and vascular therapeutic, prognostic and diagnostic testing services

Scientific and technological services, namely research and design relating thereto in the field of ophthalmology, in the field of diabetes and in the field of treatment of cardiovascular disease, cardiac disease and vascular disease; industrial analysis of the pharmaceutical preparations of others used for the treatment of ophthalmologic diseases, diabetes and cardiovascular diseases for quality control purposes; research services in the field of ophthalmology, diabetes and cardiovascular diseases; pharmaceutical and biopharmaceutical research and development; biopharmaceutical product evaluation; research in the field of treatment of cardiovascular disease, cardiac disease, and vascular disease; development of new treatments for pathologies in which vascular biology plays a critical role in the field of biopharmaceuticals
oxurion

General Information


Serial Number79239267
Word MarkOXURION
Filing DateMonday, June 25, 2018
Status700 - REGISTERED
Status DateTuesday, June 11, 2019
Registration Number5772180
Registration DateTuesday, June 11, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 26, 2019

Trademark Statements


Goods and ServicesBiopharmaceutical preparations for use in the treatment of hypertension, strokes, cardiac diseases and vascular diseases; diagnostic medical reagents, chemicals preparations and biological materials all the foregoing being in the form of spatially defined arrays and solutions and reagents for medical laboratory use in diagnosting, monitoring, and predicting diseases and for measuring and predicting response to therapy of cardiac and vascular diseases; pharmaceutical preparations for use in the treatment of hypertension, strokes, cardiac diseases and vascular diseases; pharmaceutical substances and medicines for treatment or prevention of eye disorders and diseases and of ophthalmological disorders and diseases; pharmaceutical preparations and substances for the treatment or prevention of diabetes; medicines for treating or preventing diabetes; ophthalmic medicines and surgical fluids, ophthalmic pharmaceutical preparations; pharmaceutical eye drops
Goods and ServicesMedical services; veterinary services; consultancy services, namely, consultancy in the medical, veterinary and pharmaceutical treatment of patients in the fields of ophthalmology, diabetes and cardiovascular diseases; medical services, namely, cardiac and vascular therapeutic, prognostic and diagnostic testing services
Goods and ServicesScientific and technological services, namely research and design relating thereto in the field of ophthalmology, in the field of diabetes and in the field of treatment of cardiovascular disease, cardiac disease and vascular disease; industrial analysis of the pharmaceutical preparations of others used for the treatment of ophthalmologic diseases, diabetes and cardiovascular diseases for quality control purposes; research services in the field of ophthalmology, diabetes and cardiovascular diseases; pharmaceutical and biopharmaceutical research and development; biopharmaceutical product evaluation; research in the field of treatment of cardiovascular disease, cardiac disease, and vascular disease; development of new treatments for pathologies in which vascular biology plays a critical role in the field of biopharmaceuticals

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 24, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 24, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 24, 2018
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOxurion NV
Party Type30 - Original Registrant
Legal Entity Type32 - NOT AVAILABLE
AddressBE

Party NameThromboGenics
Party Type20 - Owner at Publication
Legal Entity Type32 - NOT AVAILABLE
AddressBE

Party NameThromboGenics
Party Type10 - Original Applicant
Legal Entity Type32 - NOT AVAILABLE
AddressBE

Trademark Events


Event DateEvent Description
Thursday, August 23, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, August 24, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 28, 2018APPLICATION FILING RECEIPT MAILED
Saturday, October 13, 2018ASSIGNED TO EXAMINER
Saturday, October 13, 2018NON-FINAL ACTION WRITTEN
Sunday, October 14, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, October 25, 2018REFUSAL PROCESSED BY MPU
Thursday, October 25, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, November 9, 2018REFUSAL PROCESSED BY IB
Wednesday, January 30, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 30, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 30, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 30, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 30, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 6, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, March 6, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 6, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Saturday, March 23, 2019NOTIFICATION PROCESSED BY IB
Tuesday, March 26, 2019PUBLISHED FOR OPPOSITION
Tuesday, March 26, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 11, 2019REGISTERED-PRINCIPAL REGISTER
Thursday, June 13, 2019CHANGE OF NAME/ADDRESS REC'D FROM IB
Saturday, February 2, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 15, 2019ASSIGNED TO LIE
Wednesday, September 11, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Saturday, September 21, 2019FINAL DISPOSITION PROCESSED
Saturday, September 21, 2019FINAL DISPOSITION NOTICE SENT TO IB
Saturday, October 12, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, June 11, 2024COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED